About: Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on August 2004

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2004 (ast) наукова стаття, опублікована в серпні 2004 (uk) مقالة علمية نشرت في أغسطس 2004 (ar) scientific article published on August 2004 (en)
publication date	wds:Q37156650-E5293ABF-3CDB-4008-9F20-FDFB51AB450B
publication date	2004-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37156650-784D7A41-E757-4E04-8135-EA374222591C
language of work or name	English
cites work	wds:Q37156650-0324E448-3706-4072-897A-8BD956768B77 wds:Q37156650-082E9706-A694-4F4E-8E59-921A1AAD3298 wds:Q37156650-1406C4D9-5C7B-4DAC-8518-0A91693B6491 wds:Q37156650-23649293-9030-4CE0-B418-48BB6C5AE313 wds:Q37156650-2734CB5E-B5E4-4584-8DF8-409CF21864F7 wds:Q37156650-278D3BCD-C33A-443E-B967-D642BF187E96 wds:Q37156650-28721120-EED7-41D9-985F-37C833F406B7 wds:Q37156650-2CBB6022-35CA-4D89-B61D-FE9CA5DFB2C5 wds:Q37156650-4338A400-2DC6-4C5C-874B-98B93D977EC8 wds:Q37156650-56BAB721-B253-4B97-84DE-1E1D1777500D wds:Q37156650-6335D24C-498A-4117-9924-733BAE0EB153 wds:Q37156650-65E85578-6E13-4431-827B-9955FCCB2434 wds:Q37156650-7BE9DC35-E7C4-4E86-B196-90C91623C57F wds:Q37156650-8863E6F2-2CC6-4488-B3AB-3EDF72838D92 wds:Q37156650-9F57D5A4-7EC6-4F72-A2DF-3853ACC290C9 wds:Q37156650-A42C252F-DF56-4B90-9949-352128F15BF2 wds:Q37156650-A7FC6458-9FF5-45D4-965F-73D891CE87F6 wds:Q37156650-B5DA49F2-A49C-4BE1-9467-8666515C3A11 wds:Q37156650-C2863D00-46CC-4899-B186-CCDF6659769A wds:Q37156650-C3EACC0A-0D53-43D2-9F4D-9B0D9740D79D wds:Q37156650-CA010259-49A1-49FF-92E8-8ABA23699458 wds:Q37156650-D6A5850D-E279-4ADC-BF28-7D1CF242B83C wds:Q37156650-DFDBCDE9-DFB5-43BA-A4B1-80F532F8AE00 wds:Q37156650-ED57F3FB-9DD2-4278-95BF-378E40A35850 wds:Q37156650-EE52C4F8-7B51-4B1D-B93D-B4335F52DCCD wds:Q37156650-F4BFC19D-E4AC-4EF9-84AD-25A21E170C7B wds:Q37156650-F893239B-86A1-4DDF-BD75-6B8ACADFE0F9 wds:Q37156650-FF0BE78C-4849-455D-999B-54BDEDF91783
cites work	Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group Clinical evaluation of an automated nucleic acid isolation system Statistical methods for assessing agreement between two methods of clinical measurement High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention Strengths and limitations of commercial tests for hepatitis C virus RNA quantification External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assay Real-time detection system for quantification of hepatitis C virus genome Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay Performance Characteristics of a Quantitative, Homogeneous TaqMan RT-PCR Test for HCV RNA Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection Standardized hepatitis C virus RNA panels for nucleic acid testing assays Medical devices; classification/reclassification; restricted devices; analyte specific reagents--FDA. Final rule
author name string	wds:Q37156650-A77629F3-8D3A-45C0-8B2F-DDB0A45D032A wds:Q37156650-F99CBD7B-1EF7-4510-905A-5FAF0482AE24
author name string	Frederick S Nolte Jennifer Goforth
rdfs:label	Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (en) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (nl) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (ast)
skos:prefLabel	Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (en) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (nl) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (ast)
name	Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (en) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (nl) Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (ast)
author	wds:Q37156650-3CA91659-E2EE-4C5E-97F2-1F8C0391A50A wds:Q37156650-DC098F22-BE6E-4E69-9122-FD2489315691
author	Angela Caliendo James M Barbeau
title	wds:Q37156650-8970CF54-8137-422E-879A-E3EB09C6F180
title	Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (en)
page(s)	wds:Q37156650-01511BFC-1852-4096-981E-EC639DB18960
page(s)	3739-3746
instance of	wds:Q37156650-85D6F22B-6A66-42E0-9182-B27DE0E5A6DD
instance of	scholarly article

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software